Role and potential targeting of hepatic apurinic/apyrimidinic endonuclease-1 and cyclin-dependent kinase-4 in hepatocellular carcinoma

Author unknown

Open source

DOI
10.1139/cjpp-2017-0091
Published
2018-03
Container
Canadian Journal of Physiology and Pharmacology
Publisher
Canadian Science Publishing
Open access
unknown

Credibility signals

serious concern Score 23/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1139/cjpp-2017-0091,
  title = {Role and potential targeting of hepatic apurinic/apyrimidinic endonuclease-1 and cyclin-dependent kinase-4 in hepatocellular carcinoma},
  year = {2018},
  journal = {Canadian Journal of Physiology and Pharmacology},
  doi = {10.1139/cjpp-2017-0091},
  url = {https://doi.org/10.1139/cjpp-2017-0091}
}

RIS

TY  - JOUR
TI  - Role and potential targeting of hepatic apurinic/apyrimidinic endonuclease-1 and cyclin-dependent kinase-4 in hepatocellular carcinoma
PY  - 2018
JO  - Canadian Journal of Physiology and Pharmacology
DO  - 10.1139/cjpp-2017-0091
UR  - https://doi.org/10.1139/cjpp-2017-0091
ER  - 

APA

Role and potential targeting of hepatic apurinic/apyrimidinic endonuclease-1 and cyclin-dependent kinase-4 in hepatocellular carcinoma. (2018). Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/cjpp-2017-0091

Source records